BACKGROUND Multiple sclerosis (MS) is a heterogeneous autoimmune disease of the central nervous system. The identification of 4 different immunopathological subtypes of MS raises the question of whether these subtypes represent different patient subgroups that can be distinguished according to their leading mechanism of myelin destruction or whether this is a stage-dependent process in the deve...

The cascade of inflammatory pathogenetic mechanisms in multiple sclerosis (MS) has no specific conventional MRI correlates. Clinicians therefore stipulate improved imaging specificity to define the pathological substrates of MS in vivo including mapping of intracellular sodium accumulation. Based upon preclinical findings and results of previous sodium MRI studies in MS patients we hypothesized...

OBJECTIVE The diagnosis of multiple sclerosis (MS) presently relies on radiographic assessments of imperfect specificity. Recent data using T2* methodology for the detection of the "central vessel sign" (CVS) in MS lesions suggests this novel MRI technique may distinguish MS from other disorders. Our aim was to determine if evaluation for CVS on 3T FLAIR* MRI differentiates MS from migraine. ...

Immunohistochemical methods were used to search for Fas receptor/Fas ligand system involvement in multiple sclerosis (MS) white matter brain lesions. We found large numbers of Fas ligand (Fas-L)-bearing cells present in two acute lesions and 12 of 16 chronic MS lesions, and very few positive cells in non-inflammatory controls. Four of six brains from non-MS neuropathologic conditions associated...

Frozen brain specimens from patients with multiple sclerosis (MS) and other neurologic diseases were analyzed using immunocytochemical techniques for the presence of TNF. In brain lesions in MS, and subacute sclerosing panencephalitis, TNF+ cells were demonstrated. At the lesion site in MS, TNF+ staining is associated with both astrocytes and macrophages. These observations were not made in Alz...

MRI phase imaging in multiple sclerosis (MS) patients and in autopsy tissue have demonstrated the presence of iron depositions in white matter lesions. The accumulation of iron in some but not all lesions suggests a specific, potentially disease-relevant process, however; its pathophysiological significance remains unknown. Here, we explore the role of lesional iron in multiple sclerosis using ...

INTRODUCTION Multiple sclerosis (MS) is a condition characterized by progressive demyelination of axons and loss of white matter (WM) integrity in the CNS. Brain injury in MS patients includes both inflammatory and demyelinating changes that range from lesions that do not cause overt loss of function to those that result in complete transection of axons, long-term axonal degeneration, and thus ...

Multiple sclerosis (MS) is characterized by multifocal loss of myelin, oligodendrocytes, and axons. Potential MS therapies include enhancement of remyelination by transplantation or manipulation of endogenous oligodendrocyte progenitor cells. Characteristics of endogenous oligodendrocyte progenitors in normal human brain and in MS lesions have not been studied extensively. This report describes...

Multiple sclerosis (MS) lesion segmentation is crucial for evaluating disease burden, determining disease progression and measuring the impact of new clinical treatments. MS lesions can vary in size, location and intensity, making automatic segmentation challenging. In this paper, we propose a new supervised method to segment MS lesions from 3D magnetic resonance (MR) images using non-local mea...

multiple sclerosis (ms) is a multifactorial disease (caused by both environmental and genetic features) that could results from a demyelination of the myelin sheath. subsequently, it leads to many scars or lesions in different places within the central nervous system. the symptoms that occur depend on the site and rigorousness of the lesions and this is why people with ms experience different s...